Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Stevens-Johnson Syndrome × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vasculitis 1 Urogenital Neoplasms 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Pemphigoid, Benign Mucous Membrane 1 Melanoma 1 Inflammatory Bowel Diseases 1 Hematologic Neoplasms 1 Granulomatous Disease, Chronic 1 Cytokine Release Syndrome 1 Crohn Disease 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Aneurysm 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02126020 2017-04-07

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Massachusetts Eye and Ear Infirmary

Phase 1/2 Withdrawn

Pemphigoid, Benign Mucous Membrane, Stevens-Johnson Syndrome, Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡